Search This Blog

Thursday, November 7, 2019

Achillion Pharmaceuticals EPS beats by $0.02

Achillion Pharmaceuticals (NASDAQ:ACHN): Q3 GAAP EPS of -$0.14 beats by $0.02.
Cash & equivalents of $229M.
The company’s acquisition by Alexion is expected to close by 1H20.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)